Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain

NCT02455999 is registered in ClinicalTrials.gov with Sylentis, S.A. as lead sponsor.

NCT NCT02455999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02455999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain
Lead sponsor
Sylentis, S.A.
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2015
Completion date
Not reported
Enrollment
66 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome, ocular pain